Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ACTRN12625000609459) titled 'Alternate-weekly medication dosing for weight maintenance' on June 12.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Monash University
Condition:
Obesity
Obesity
Metabolic and Endocrine - Metabolic disorders
Intervention:
Semaglutide or tirzepatide administered at reduced frequency (fortnightly) for 24 weeks.
The dose administered every fortnight will be the numerical weekly dose at recruitment, but given every fortnight rather than weekly.
Subcutaneous injection.
Adherence based on self-report....
Recruitment Status: Not Recruit...